Bio Special
John Graham, Zuellig Pharma Group CEO, Explores Strategic Partnership with Substipharm Biologics to Transform Healthcare in Asia
In an insightful interview with BioPharma APAC, John Graham, Group CEO of Zuellig Pharma, shares details about the strategic partnership with Substipharm B...
February 05, 2024 | Interaction
Merck's Strategic Agreement with Heavy Water Board Boosts Local Manufacturing for Deuterated Compounds in India
In a recent interview with BioPharma APAC, Jean Charles Wirth, Executive Vice President of Science & Laboratory Solutions at Merck, sheds light...
January 26, 2024 | Interview
Revolutionizing Genomic Research: Thermo Fisher's Axiom™ PangenomiX Array's Breakthroughs in Disease and Pharmacogenomic Studies
In an insightful interaction with BioPharma APAC, Joanne Tsarouha, Sr. Product Manager of Microarray Technology at Thermo Fisher Scientific, delves into th...
January 24, 2024 | Expert Insight
2024 Biopharma Outlook: 24 Trends, Innovations, and FDA's Critical Role
As we step into 2024, the biopharmaceutical industry is poised for an era of unprecedented innovation and transformative breakthroughs. From cutting-edge t...
January 01, 2024 | News
2024's Biopharma Roadmap: Top 24 Biopharma Trends to Watch in 2024
As we usher in 2024, the biopharma landscape stands at the forefront of innovation and transformative breakthroughs. The coming year promises to be a dynam...
December 29, 2023 | News
Pioneering Precision: Top 15 Clinical and Lab Diagnostic Companies to Watch in 2025
As the healthcare landscape continues to evolve, diagnostic capabilities play a pivotal role in shaping the trajectory of patient care. In 2025, a ...
January 01, 2025 | News
Revolutionizing Tomorrow: Top 24 Emerging Biotech Innovations to Watch in 2024
Unveiling the Pioneering Companies Poised to Transform Healthcare 1. QuantumGen Website: quantumgen.com Location: San Francisco, CA, USA Focu...
December 29, 2023 | News
Breakthroughs Unveiled: A Year of Groundbreaking Novel Drug Approvals in 2023
Innovative drugs often mean new treatment options for patients and advances in health care for the American public. When it comes the development of new dr...
December 29, 2023 | News
Revolutionizing Drug Discovery: 15 AI Companies to Watch in 2024
As we step into 2024, let's explore 15 AI companies at the forefront of this transformative journey. Atomwise: Revolutionizing Virtual Screening Atomw...
December 27, 2023 | News
Biotech and Biopharma Industry Trends: What to Watch for in 2024
In a year-round up preview, Dr. Senthil Sockalingam, Head of IQVIA Biotech in Japan-Asia Pacific and Chief Medical Officer of IQVIA Asia Pacific, offers a ...
December 18, 2023 | Opinion | By Dr Senthil Sockalingam, Head, IQVIA Biotech in Japan-Asia Pacific; Chief Medical Officer, IQVIA Asia Pacific
Advancing Lung Cancer Treatment: Insights from Professor Benjamin Solomon on the ALINA Study and the Future of ALK-Positive NSCLC
In an exclusive BioPharma APAC interview, Professor Benjamin Solomon, a distinguished Medical Oncologist at the Peter MacCallum Cancer Centre, Australia, a...
December 18, 2023 | News
Examining Financial Ruin, Advocating for Change, and Fostering Collaboration in Cancer Care Economics Across the Asia Pacific Region
In a recent email interview with BioPharma APAC, Dr. Nirmala Bhoo-Pathy, a distinguished Professor of (Clinical) Epidemiology at the Faculty of Medicine, U...
December 13, 2023 | News
Combatting Cancer Disparities: Addressing Challenges and Expanding Access to Care in Low- and Middle-Income Countries
In an exclusive email interview with BioPharma APAC, Carmen Auste, the CEO of Cancer Warriors Foundation Philippines and Vice President of Cancer Coalition...
December 13, 2023 | News
IQVIA Experts Share Perspectives on Challenges, Opportunities, and the Transformative Role of DCTs in Asia Pacific
In a dynamically evolving landscape of clinical research, the Asia Pacific (APAC) region has emerged as a key player in adopting Decentralized Clinical Tri...
December 13, 2023 | News
Most Read
- Why Cell Therapy Systems Are Going Automatic: A New Era of Manufacturing
- Pioneering Precision: Top 15 Clinical and Lab Diagnostic Companies to Watch in 2025
- 2025 Pharma and Medical Device Trends for Manufacturing Leaders
- 25 High-Value Drugs Losing Patent Protection in 2025: What It Means for Healthcare
- BioPharma Trends 2025: 25 Key Insights Shaping Asia Pacific's Future
- Driving Oncology Forward: 25 Companies Redefining Antibody-Drug Conjugates (ADCs) in 2025
- 25 Biopharma Leaders Shaping a Sustainable 2025: Innovation Meets Environmental Responsibility
- 25 Leading AI Companies to Watch in 2025: Transforming Drug Discovery and Precision Medicine
- Mr. Brendan O’Callaghan Discusses Sanofi’s Singapore Modulus Facility: Advancing Biopharma Manufacturing and Pandemic Preparedness
- Shaping the Future of PCV Care: Insights from Roche’s Stefan Scheidl on the SALWEEN Trial
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Shaping a Health Innovation Hub: Alessandro Falcone Reflects on JLABS Singapore’s Milestone Year and Future Goals
Bio Jobs
- Ravindra Rao Joins GOBI Technologies as Director of Life Sciences – APAC
- Amgen Announces $900 Million Expansion of Ohio Biomanufacturing Facility, Boosting Investment to Over $1.4 Billion
- Thermo Fisher Scientific Appoints Former CVS Health CEO Karen S. Lynch to Board of Directors
- Merck KGaA Reshapes Leadership for the Future with Key Executive Moves
- Aarian Health Appoints Thomas Keller as Business Director to Drive Innovation and Growth
- Top Management Shakeups of 2024: Redefining Pharma, Biopharma, and Biotech Leadership
News
